On this episode, we’re breaking down the landmark DOSE VF study – DOuble SEquential External Defibrillation for Refractory Ventricular Fibrillation (DOSE VF) – that was recently published in the NEJM with lead investigator Dr. Sheldon Cheskes.
Study Design: Cluster randomized controlled trial
Research Question: The objective of this trial (Double Sequential External Defibrillation for Refractory Ventricular Fibrillation [DOSE VF]) was to evaluate DSED and VC defibrillation as compared with standard defibrillation in patients who remain in refractory ventricular fibrillation during out-of-hospital cardiac arrest.